Failure of specific active immunotherapy in lung cancer.

A randomized trial comparing routine follow-up with a treatment regimen aimed at increasing specific anti-tumour immunity has been carried out in 95 patients after total surgical excision of lung cancer (not small-cell). Treatment consisted of inoculation with an autologous irradiated suspension of...

Descripción completa

Detalles Bibliográficos
Autores principales: Souter, R. G., Gill, P. G., Gunning, A. J., Morris, P. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1981
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010816/
https://www.ncbi.nlm.nih.gov/pubmed/7028069
_version_ 1782136401550114816
author Souter, R. G.
Gill, P. G.
Gunning, A. J.
Morris, P. J.
author_facet Souter, R. G.
Gill, P. G.
Gunning, A. J.
Morris, P. J.
author_sort Souter, R. G.
collection PubMed
description A randomized trial comparing routine follow-up with a treatment regimen aimed at increasing specific anti-tumour immunity has been carried out in 95 patients after total surgical excision of lung cancer (not small-cell). Treatment consisted of inoculation with an autologous irradiated suspension of tumour cells combined with a small dose of C. parvum given intradermally during convalescence. Although treatment was associated with virtually no side effects, there has been no apparent benefit and input to the trial has now stopped.
format Text
id pubmed-2010816
institution National Center for Biotechnology Information
language English
publishDate 1981
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20108162009-09-10 Failure of specific active immunotherapy in lung cancer. Souter, R. G. Gill, P. G. Gunning, A. J. Morris, P. J. Br J Cancer Research Article A randomized trial comparing routine follow-up with a treatment regimen aimed at increasing specific anti-tumour immunity has been carried out in 95 patients after total surgical excision of lung cancer (not small-cell). Treatment consisted of inoculation with an autologous irradiated suspension of tumour cells combined with a small dose of C. parvum given intradermally during convalescence. Although treatment was associated with virtually no side effects, there has been no apparent benefit and input to the trial has now stopped. Nature Publishing Group 1981-10 /pmc/articles/PMC2010816/ /pubmed/7028069 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Souter, R. G.
Gill, P. G.
Gunning, A. J.
Morris, P. J.
Failure of specific active immunotherapy in lung cancer.
title Failure of specific active immunotherapy in lung cancer.
title_full Failure of specific active immunotherapy in lung cancer.
title_fullStr Failure of specific active immunotherapy in lung cancer.
title_full_unstemmed Failure of specific active immunotherapy in lung cancer.
title_short Failure of specific active immunotherapy in lung cancer.
title_sort failure of specific active immunotherapy in lung cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010816/
https://www.ncbi.nlm.nih.gov/pubmed/7028069
work_keys_str_mv AT souterrg failureofspecificactiveimmunotherapyinlungcancer
AT gillpg failureofspecificactiveimmunotherapyinlungcancer
AT gunningaj failureofspecificactiveimmunotherapyinlungcancer
AT morrispj failureofspecificactiveimmunotherapyinlungcancer

Ejemplares similares